The present invention relates to a composition based on components of natural origin, in particular ozonized olive oil and liquid vegetable extracts, for the topical treatment of vaginosis and/or vulvovaginitis of bacterial and/or fungal origin.

The present invention relates to a composition based on components of natural origin, in particular ozonized olive oil and liquid vegetable extracts, for the topical treatment of vaginosis and/or vulvovaginitis of bacterial and/or fungal origin.

A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a dressing gauze or bandage without prior cleaning of said skin or mucosal surfaces, wherein distributed on said dressing is an effective amount of a composition containing beeswax; an oleaginous base, vitamins and a pharmaceutically acceptable excipient; then removing said dressing at least twice per day without damaging the patient's skin or mucosal surfaces due to removal of the dressing.

A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a dressing gauze or bandage without prior cleaning of said skin or mucosal surfaces, wherein distributed on said dressing is an effective amount of a composition containing beeswax; an oleaginous base, vitamins and a pharmaceutically acceptable excipient; then removing said dressing at least twice per day without damaging the patient's skin or mucosal surfaces due to removal of the dressing.

A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a dressing gauze or bandage without prior cleaning of said skin or mucosal surfaces, wherein distributed on said dressing is an effective amount of a composition containing beeswax; an oleaginous base, vitamins and a pharmaceutically acceptable excipient; then removing said dressing at least twice per day without damaging the patient's skin or mucosal surfaces due to removal of the dressing.

A composition and method for treating equine sarcoids includes providing a composition ingestible by a horse wherein the composition comprises Manuka honey, chia seeds, and spirulina powder. A dosage, being an effective amount of the composition, is fed to a horse having one or more equine sarcoids.

A composition and method for treating equine sarcoids includes providing a composition ingestible by a horse wherein the composition comprises Manuka honey, chia seeds, and spirulina powder. A dosage, being an effective amount of the composition, is fed to a horse having one or more equine sarcoids.

A composition and method for treating equine sarcoids includes providing a composition ingestible by a horse wherein the composition comprises Manuka honey, chia seeds, and spirulina powder. A dosage, being an effective amount of the composition, is fed to a horse having one or more equine sarcoids.

Prior art describes methods for making whole-plant extracts from the Cannabis plant. Terpenes and cannabinoids are classes of compounds found inherently in those extracts. But, because those extracts contain hundreds of different, and sometimes counteracting, compounds, they are not the most effective treatments for common health issues. Specific terpenes and cannabinoids may be isolated and chosen for their use for specific conditions. Examples of the present invention differ from the prior art by selecting isolated compounds (Like the cannabinoid THC and the terpene Myrcene) and specifically combining them with essential and topical agents to produce targeted treatments.

Prior art describes methods for making whole-plant extracts from the Cannabis plant. Terpenes and cannabinoids are classes of compounds found inherently in those extracts. But, because those extracts contain hundreds of different, and sometimes counteracting, compounds, they are not the most effective treatments for common health issues. Specific terpenes and cannabinoids may be isolated and chosen for their use for specific conditions. Examples of the present invention differ from the prior art by selecting isolated compounds (Like the cannabinoid THC and the terpene Myrcene) and specifically combining them with essential and topical agents to produce targeted treatments.